XML 55 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2015
Stock Compensation  
Summary of the components of stock-based compensation expense in the condensed consolidated statements of operations

 

 

Selling, general, and administrative expenses

 

$

1,071 

 

Research and development expenses

 

53 

 

 

 

 

 

Total

 

$

1,124 

 

 

Summary of the status of time-based stock options

 

 

 

 

Number of
Shares

 

Weighted-Average
Exercise Price

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic Value (In
thousands)

 

Outstanding at August 1, 2015

 

 

 

 

 

Granted

 

1,106,875 

 

$

12.00 

 

9.58 

 

$

 

Exercised

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

Outstanding at December 31, 2015

 

1,106,875 

 

$

12.00 

 

9.58 

 

$

 

Exercisable at December 31, 2015

 

 

 

 

 

Vested and expected to vest at December 31, 2015

 

1,106,875 

 

$

12.00 

 

9.58 

 

$

 

 

Schedule of fair value assumptions

 

 

Weighted average grant date fair value

 

$4.03

 

Risk-free interest rate

 

1.67%-1.70%

 

Expected life (years)

 

5.73-5.97

 

Estimated volatility factor

 

47.68%-47.95%

 

Expected dividends

 

None

 

 

Summary of the time-based SARs

 

 

 

 

Number
of
Shares

 

Weighted-Average
Exercise Price

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

Aggregate
Intrinsic Value
(In thousands)

 

Outstanding at August 1, 2015

 

 

 

 

 

Granted

 

165,000 

 

$

12.00 

 

9.71 

 

$

 

Exercised

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

Outstanding at December 31, 2015

 

165,000 

 

$

12.00 

 

9.71 

 

$

 

Exercisable at December 31, 2015

 

 

 

 

 

Vested and expected to vest at December 31, 2015

 

165,000 

 

$

12.00 

 

9.71 

 

$

 

 

Time-Based Stock Appreciation Rights  
Stock-based Compensation  
Schedule of fair value assumptions

At reporting date, December 31, 2015:

 

Weighted average grant date fair value

$1.74

Risk-free interest rate

2.24%-2.25%

Expected life (years)

6.40-6.54

Estimated volatility factor

47.5%-47.7%

Expected dividends

None

 

Restricted Stock Units  
Stock-based Compensation  
Schedule of unvested performance shares

. A summary of the Company’s performance-based restricted stock awards for the five months ended December 31, 2015 is as follows:

 

 

 

Number of
Shares

 

Weighted-Average
Grant Date Fair 
Value

 

Non-vested performance-based RSUs at August 1, 2015

 

 

 

Granted

 

596,491 

 

$

6.34 

 

Vested

 

 

 

Forfeited or expired

 

 

 

Non-vested performance-based RSUs at December 31, 2015

 

596,491 

 

$

6.34 

 

 

Phantom Stock Options  
Stock-based Compensation  
Schedule of unvested performance shares

A summary of the Company’s performance-based Phantom Stock for the five months ended December 31, 2015 is as follows:

 

 

 

Number of
Shares

 

Weighted-Average
Grant Date Fair Value

 

Non-vested performance-based phantom shares at August 1, 2015

 

 

 

Granted

 

154,502 

 

$

6.34 

 

Vested

 

 

 

Forfeited or expired

 

 

 

Non-vested performance-based phantom shares at December 31, 2015

 

154,502 

 

$

6.34 

 

 

Director Shares  
Stock-based Compensation  
Schedule of fair value assumptions

 

 

Risk-free interest rate

1.96 

%

Expected life (years)

6.47 

 

Estimated volatility factor

31.16 

%

Expected dividends

None

 

 

Restricted Stock  
Stock-based Compensation  
Schedule of nonvested shares

A summary of the Company’s time-based restricted stock awarded to the Board of Directors for the five months ended December 31, 2015 is as follows:

 

 

 

Number of
Shares

 

Weighted-Average
Grant Date Fair Value

 

Non-vested time-based restricted stock at August 1, 2015

 

 

 

Granted

 

26,387 

 

$

6.34 

 

Vested

 

 

 

Forfeited or expired

 

 

 

Non-vested time-based restricted stock at December 31, 2015

 

26,387 

 

$

6.34